KRAS and colorectal carcinoma: Lingeng Lu et al., using a 3D organoid model with KRAS mutant (MT) and KRAS wild-type (WT) CRC cells [34], demonstrated that E2 supplementation had no effect on KRAS MT cells when grown in a glutamine-depleted medium but significantly inhibited WT cells.